GlassScriptPhysician profile
Marcus L Davis
NPI 1962813840
$1,429.24
in general payments reported to CMS, 2019-2025
13 companies · $603 in 2025
The $603 reported for 2025 was more than what 93% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $62.68 · 2023: $59.72 · 2024: $482 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $428.13 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $171.43 | 2021 | |
| Lilly USA, LLC | $165.53 | 2023-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $130.61 | 2024-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $117.78 | 2024-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $108.69 | 2024-2025 | |
| Abbvie INC. | $94.59 | 2023-2025 | Ubrelvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.27 | 2024 | Jardiance |
| Dynavax Technologies Corporation | $42.00 | 2024 | Heplisav-B |
| Viiv Healthcare Company | $40.53 | 2022-2024 | Apretude |
| Tms Neurohealth Centers INC. | $37.00 | 2025 | Tms Neurohealth Centers INC. |
| Glaxosmithkline, LLC. | $21.72 | 2025 | Arexvy, Shingrix |
| Chiesi USA, INC. | $17.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.